SCHEMBL291891

SCHEMBL291891

CCc1ccccc1N1CC(C)(C)NCC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.41
MGLL Q99685 1/20 0.40
ALOX5 P09917 1/20 0.39
TSHR P16473 2/20 0.37
GAA P10253 3/20 0.36
OPRM1 P35372 2/20 0.36
OPRL1 P41146 1/20 0.36
GFER P55789 1/20 0.36
THRB P10828 1/20 0.35
BRPF1 P55201 1/20 0.34
NOTUM Q6P988 1/20 0.34
ALDH1A1 P00352 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HCAR1 Q9BXC0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL294226 0.83 DDB1 (0.49) LMNAMEN1MAPTKMT2AL3MBTL1
SCHEMBL292679 0.82 HSD11B1 (0.46) MAPTMGLLALOX5OPRM1ALDH1A1
SCHEMBL292960 0.82 MEN1 (0.53) MEN1KMT2AMGLLOPRM1OPRL1
SCHEMBL292189 0.79 ALDH1A1 (0.48) MEN1MAPTKMT2AMGLLGAA
SCHEMBL291894 0.79 MAPT (0.43) MEN1MAPTKMT2AGAAOPRM1
SCHEMBL292701 0.78 AR (0.44) MEN1MAPTKMT2AL3MBTL1NOTUM
SCHEMBL292789 0.78 REN (0.40) OPRM1OPRL1ALDH1A1
SCHEMBL292445 0.77 REN (0.38) MAPTOPRM1OPRL1ALDH1A1
SCHEMBL293635 0.77 RECQL (0.40) MEN1KMT2AOPRM1OPRL1HCAR1
SCHEMBL292591 0.76 REN (0.39) OPRM1OPRL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
WO-2011065519-A1 SUBSTITUTED OXOPIPERAZINE COMPOUND 第一三共株式会社 (JP) 2011-06-03 WO disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 LMNA 1720/4885MEN1 869/4885MAPT 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.